KINETO Lab is a member of the RASopathies network, which was launched by in 2016, for development of diagnosis and targeted therapy of rasopathies. Continuation of this project for development of KRas targeting small molecules, inhibiting tumor cells carrying different KRas mutations (G12C, D, V) on in vitro and in vivo tumor models is supported until 2024.